There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Myasthenia gravis (MG) patients with autoantibodies to muscle-specific tyrosine kinase
(MuSK) represent a distinct subset of those with this disease. Treatment and outcomes
data in these patients are limited and conflicting.